Cart
sales@molnova.com
Home -
Products -
Others -
Other Targets -
Orcinol 1-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside
Orcinol 1-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside
CAS No. 868557-54-4
Orcinol 1-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside( —— )
Catalog No. M31830 CAS No. 868557-54-4
Orcinol 1-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside has antioxidative activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 666 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOrcinol 1-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside
-
NoteResearch use only, not for human use.
-
Brief DescriptionOrcinol 1-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside has antioxidative activity.
-
DescriptionOrcinol 1-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside has antioxidative activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number868557-54-4
-
Formula Weight418.4
-
Molecular FormulaC18H26O11
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Daphnoretin
Daphnoretin has anticancer effects on leukemia, osteosarcoma and uterine cervix cancer cells, might through promoting apoptosis in a mitochondria-mediated way.
-
Tert-butyl undec-10-...
Tert-butyl undec-10-enoate (Tert-Butyl 10-undecenoate) is an organic synthesis intermediate.
-
Oxindole
Oxindole is an aromatic heterocyclic building block.?2-indolinone derivatives have become lead compounds in the research of kinase inhibitors.Oxindole structure has been used in receptor tyrosine kinases (RTKs) inhibitors such as SU4984 and intedanib, the RTK family represents an important therapeutic target for anti-cancer drug development.
